Hangzhou Biotest Biotech Co.,Ltd.
SSE:688767.SS
32.14 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 1,590.965 | 1,907.431 | 1,939.981 | 1,367.736 | 261.171 | 13.808 | 16.337 | 8.904 |
| Short Term Investments
| 60.258 | 0 | 100.065 | 360.841 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,651.223 | 1,907.431 | 2,040.045 | 1,728.578 | 261.171 | 13.808 | 16.337 | 8.904 |
| Net Receivables
| 101.728 | 64.685 | 38.823 | 146.907 | 96.264 | 40.231 | 29.122 | 21.942 |
| Inventory
| 73.401 | 99.324 | 135.197 | 141.704 | 92.388 | 36.381 | 34.787 | 28.216 |
| Other Current Assets
| 51.571 | 15.369 | 25.629 | 15.521 | 18.163 | 7.933 | 5.424 | 7.192 |
| Total Current Assets
| 1,877.923 | 2,086.808 | 2,235.269 | 2,032.71 | 467.986 | 98.353 | 85.67 | 66.254 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 408.808 | 261.577 | 244.677 | 231.016 | 138.651 | 88.836 | 43.725 | 37.296 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 275.16 | 208.71 | 213.706 | 20.349 | 20.746 | 21.326 | 21.579 | 21.989 |
| Goodwill and Intangible Assets
| 275.16 | 208.71 | 213.706 | 20.349 | 20.746 | 21.326 | 21.579 | 21.989 |
| Long Term Investments
| -50.959 | 2.841 | 4.191 | 3.092 | 0.399 | 0 | 0 | 0 |
| Tax Assets
| 11.797 | 14.442 | 12.808 | 3.007 | 1.521 | 1.092 | 1 | 0.99 |
| Other Non-Current Assets
| 79.403 | 8.033 | 40.566 | 141.335 | 4.612 | 0.837 | 2.661 | 0.986 |
| Total Non-Current Assets
| 724.209 | 492.762 | 515.948 | 398.799 | 165.93 | 112.091 | 68.964 | 61.261 |
| Total Assets
| 2,602.132 | 2,579.57 | 2,751.217 | 2,431.509 | 633.916 | 210.443 | 154.635 | 127.515 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 56.449 | 56.151 | 88.722 | 224.325 | 110.894 | 42.745 | 28.042 | 19.779 |
| Short Term Debt
| 0.441 | 0.589 | 0.349 | 5.64 | 11.089 | 20.111 | 20.095 | 20.134 |
| Tax Payables
| 4.536 | 3.139 | 9.574 | 41.15 | 45.544 | 0.413 | 0.565 | 0.731 |
| Deferred Revenue
| 0 | 0 | 44.685 | 85.143 | 68.41 | 5.756 | 0.565 | 5.442 |
| Other Current Liabilities
| 117.192 | 89.546 | 27.75 | -38.698 | 14.121 | 2.981 | 6.582 | 6.445 |
| Total Current Liabilities
| 178.617 | 149.426 | 171.08 | 317.56 | 190.582 | 72.006 | 55.849 | 47.088 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0 | 0 | 2.193 | 4.55 | 0 | 12.018 | 0 | 0 |
| Deferred Revenue Non-Current
| 11.169 | 8.687 | 6.43 | 1.25 | 0.311 | 0.472 | 0.633 | 0.794 |
| Deferred Tax Liabilities Non-Current
| 0 | 0.708 | 0.792 | -1.25 | 0 | 12.018 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 14.855 | 0 | 6.99 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 11.169 | 9.395 | 17.84 | 5.799 | 0.311 | 12.49 | 0.633 | 0.794 |
| Total Liabilities
| 189.786 | 158.821 | 188.92 | 323.359 | 190.892 | 84.495 | 56.481 | 47.882 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 106.667 | 106.667 | 106.667 | 106.667 | 80 | 80 | 80 | 80 |
| Retained Earnings
| 1,489.693 | 1,457.032 | 1,585.112 | 1,131.458 | 311.201 | 28.589 | 3.764 | -13.074 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 38.213 | 54.542 | 54.035 | 52.937 | 18.371 | 15.094 | 0.417 |
| Other Total Stockholders Equity
| 813.116 | 813.332 | 814.938 | 814.938 | 0 | 18.371 | 14.977 | 12.909 |
| Total Shareholders Equity
| 2,409.476 | 2,415.243 | 2,561.26 | 2,107.098 | 444.138 | 126.961 | 98.859 | 80.252 |
| Total Equity
| 2,412.346 | 2,420.749 | 2,562.297 | 2,108.149 | 443.024 | 125.948 | 98.153 | 79.633 |
| Total Liabilities & Shareholders Equity
| 2,602.132 | 2,579.57 | 2,751.217 | 2,431.509 | 633.916 | 210.443 | 154.635 | 127.515 |